Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-Shot Liposomal Bupivacaine vs. Liposomal Bupivacaine Combined With Dexamethasone Following Anterior Cruciate Ligament Reconstruction: A Prospective Randomized Controlled Trial

NCT06006624 is registered in ClinicalTrials.gov with Rothman Institute Orthopaedics as lead sponsor.

NCT NCT06006624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06006624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-Shot Liposomal Bupivacaine vs. Liposomal Bupivacaine Combined With Dexamethasone Following Anterior Cruciate Ligament Reconstruction: A Prospective Randomized Controlled Trial
Lead sponsor
Rothman Institute Orthopaedics
Phase
Phase 4
Overall status
Unknown status
Start date
August 21, 2023
Completion date
October 30, 2024
Enrollment
154 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acl, postoperative pain